Fusaric acid: a novel agent and mechanism to treat HNSCC.
about
Fusaric Acid Induces DNA Damage and Post-Translational Modifications of p53 in Human Hepatocellular Carcinoma (HepG2 ) Cells.Fusaric Acid immunotoxicity and MAPK activation in normal peripheral blood mononuclear cells and Thp-1 cellsEffects of fusaric acid treatment on HEp2 and docetaxel-resistant HEp2 laryngeal squamous cell carcinoma.Knockdown of metallopanstimulin-1 inhibits NF-κB signaling at different levels: the role of apoptosis induction of gastric cancer cells.Determination of oral bioavailability of fusaric acid in male Sprague-Dawley rats.Docking studies and network analyses reveal capacity of compounds from Kandelia rheedii to strengthen cellular immunity by interacting with host proteins during tuberculosis infection.
P2860
Fusaric acid: a novel agent and mechanism to treat HNSCC.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Fusaric acid: a novel agent and mechanism to treat HNSCC.
@en
type
label
Fusaric acid: a novel agent and mechanism to treat HNSCC.
@en
prefLabel
Fusaric acid: a novel agent and mechanism to treat HNSCC.
@en
P2093
P2860
P1476
Fusaric acid: a novel agent and mechanism to treat HNSCC.
@en
P2093
Brendan C Stack
Christopher S Hollenbeak
J Paul Hansen
James M Ruda
Jeff Jaglowski
Joseph Shvidler
P2860
P356
10.1016/J.OTOHNS.2004.02.038
P577
2004-07-01T00:00:00Z